Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Dark seed : no one knows what evil grows / / an ecological thriller by Lawrence Verigin
| Dark seed : no one knows what evil grows / / an ecological thriller by Lawrence Verigin |
| Autore | Verigin Lawrence <1965-> |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | [Place of publication not identified] : , : Promontory Press, , 2018 |
| Descrizione fisica | 1 online resource (479 p.) |
| Disciplina | 813.6 |
| Soggetto topico |
Pharmaceutical industry - Corrupt practices
Food - Biotechnology Plant genetic engineering |
| ISBN |
1-927559-18-9
1-927559-17-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Title Page; Copyright; Dedication; Prologue; Chapter 1; Chapter 2; Chapter 3; Chapter 4; Chapter 5; Chapter 6; Chapter 7; Chapter 8; Chapter 9; Chapter 10; Chapter 11; Chapter 12; Chapter 13; Chapter 14; Chapter 15; Chapter 16; Chapter 17; Chapter 18; Interlogue 1; Chapter 19; Chapter 20; Chapter 21; Chapter 22; Chapter 23; Chapter 24; Chapter 25; Chapter 26; Chapter 27; Chapter 28; Chapter 29; Chapter 30; Chapter 31; Chapter 32; Chapter 33; Chapter 34; Chapter 35; Interlogue 2; Chapter 36; Chapter 37; Chapter 38; Chapter 39; Chapter 40; Chapter 41; Chapter 42; Interlogue 3
Chapter 43Chapter 44; Chapter 45; Chapter 46; Chapter 47; Chapter 48; Chapter 49; Chapter 50; Chapter 51; Chapter 52; Chapter 53; Epilogue; Acknowledgments; About the Author |
| Record Nr. | UNINA-9910157814703321 |
Verigin Lawrence <1965->
|
||
| [Place of publication not identified] : , : Promontory Press, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Devalued and distrusted [[electronic resource] ] : can the pharmaceutical industry restore its broken image? / / John L. LaMattina
| Devalued and distrusted [[electronic resource] ] : can the pharmaceutical industry restore its broken image? / / John L. LaMattina |
| Autore | LaMattina John L |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley, 2013 |
| Descrizione fisica | 1 online resource (137 p.) |
| Disciplina | 338.4/76151 |
| Soggetto topico | Pharmaceutical industry - Corrupt practices |
| ISBN |
1-118-51132-8
1-283-91742-4 1-118-51129-8 |
| Classificazione | MED071000 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts. |
| Record Nr. | UNINA-9910141533103321 |
|
LaMattina John L
|
||
| Hoboken, N.J., : Wiley, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Devalued and distrusted : can the pharmaceutical industry restore its broken image? / / John L. LaMattina
| Devalued and distrusted : can the pharmaceutical industry restore its broken image? / / John L. LaMattina |
| Autore | LaMattina John L |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley, 2013 |
| Descrizione fisica | 1 online resource (137 p.) |
| Disciplina | 338.4/76151 |
| Soggetto topico | Pharmaceutical industry - Corrupt practices |
| ISBN |
1-118-51132-8
1-283-91742-4 1-118-51129-8 |
| Classificazione | MED071000 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts. |
| Record Nr. | UNINA-9910824681403321 |
|
LaMattina John L
|
||
| Hoboken, N.J., : Wiley, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Health scams! [[electronic resource] ] : don't take the risk
| Health scams! [[electronic resource] ] : don't take the risk |
| Pubbl/distr/stampa | [Rockville, Md.] : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Women's Health, Office of Enforcement, , [2007?] |
| Descrizione fisica | 1 online resource (4 unnumbered pages : color illustrations |
| Soggetto topico |
Quacks and quackery
Medical misconceptions Medical care - Corrupt practices Pharmaceutical industry - Corrupt practices Deceptive advertising Fraud |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Health scams! |
| Record Nr. | UNINA-9910696906803321 |
| [Rockville, Md.] : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Women's Health, Office of Enforcement, , [2007?] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Journal of pharmaceutical negative results
| Journal of pharmaceutical negative results |
| Pubbl/distr/stampa | Mumbai, India : , : Medknow Publications and Media Pvt. Ltd., , ©2010- |
| Descrizione fisica | 1 online resource |
| Disciplina | [E] |
| Soggetto topico |
Pharmaceutical industry - Corrupt practices
Pharmaceutical industry Industrie pharmaceutique - Pratiques déloyales Health |
| Soggetto genere / forma | Periodicals. |
| Soggetto non controllato | Health |
| ISSN | 2229-7723 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | PNR |
| Record Nr. | UNINA-9910139319203321 |
| Mumbai, India : , : Medknow Publications and Media Pvt. Ltd., , ©2010- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pay-for-delay deals : limiting competition and costing consumers : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, first session, July 23, 2013
| Pay-for-delay deals : limiting competition and costing consumers : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, first session, July 23, 2013 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Printing Office, , 2013 |
| Descrizione fisica | 1 online resource (iii, 128 pages) |
| Collana | S. hrg. |
| Soggetto topico |
Drugs - United States
Prescription pricing - United States Pharmaceutical industry - Corrupt practices - United States Generic drugs - United States Competition - United States Consumer protection - United States Patent laws and legislation - United States Competition Consumer protection Drugs Generic drugs Patent laws and legislation Pharmaceutical industry - Corrupt practices Prescription pricing |
| Soggetto genere / forma |
Legislative hearings.
Patents. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Pay-for-delay deals |
| Record Nr. | UNINA-9910705434303321 |
| Washington : , : U.S. Government Printing Office, , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The role of Purdue Pharma and the Sackler family in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020
| The role of Purdue Pharma and the Sackler family in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2021 |
| Descrizione fisica | 1 online resource (iii, 62 pages) + + 2 errata (1 page) |
| Disciplina | 4.OV 2:116-130 |
| Soggetto topico |
Opioid abuse - United States
Pharmaceutical industry - Corrupt practices - United States Drugs - United States - Marketing Oxycodone abuse - United States Corruption Drugs - Marketing Opioid abuse Oxycodone abuse Pharmaceutical industry - Corrupt practices |
| Soggetto genere / forma | Legislative hearings. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Role of Purdue Pharma and the Sackler family in the opioid epidemic |
| Record Nr. | UNINA-9910715330703321 |
| Washington : , : U.S. Government Publishing Office, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
